Keck School of Medicine of USC
We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.
I SPY 2.2: Responsive, Adaptive Trial to Prioritize Promising Investigational Agents in Stage II/III BC When They Matter Most
By
Keck School of Medicine of USC
FEATURING
Laura Esserman
By
Keck School of Medicine of USC
FEATURING
Laura Esserman
Login to view comments.
Click here to Login
9th Annual USC Multi-Disciplinary Breast Cancer Symposium